-
公开(公告)号:US20220276258A1
公开(公告)日:2022-09-01
申请号:US17631414
申请日:2020-07-29
申请人: Larimar Therapeutics, Inc. , The United States of America, as represented by the Secretary, Department of Health and Human Servic
IPC分类号: G01N33/68
摘要: The present disclosure provides methods for determining the amount of FXN or FXN fusion protein in a sample, e.g, a tissue sample, by using mass spectrometry.